Popular Articles

New Gene For Autism Gives Hope For Future
Scientists have discovered that abnormalities in a gene important for learning and memory are a cause of autism. The University of Aberdeen finding could hold the key to the future development of new treatments for autism - a brain development disorder which affects how a person communicates and relates to others. In a study published today in the Journal of Medical Genetics the researchers explain how their investigations into the gene EIF4E began with the study of one child with severe autism.
buy viagra
Molecule Helps Breast Cancer Cells To Survive In The Bone Marrow
Patients who survive an initial diagnosis of breast cancer often succumb to the disease years later when the cancer shows up in a different part of the body. Now, scientists have identified key signals that support the long term survival of breast cancer cells after they have spread to the bone marrow. The research, published by Cell Press in the July issue of the journal Cancer Cell, may lead to development of treatment strategies that decrease the likelihood of breast cancer recurrence in the bone and other organs.
News of the day
Experts Support National Public Reporting Of Healthcare-Associated Infections
Five organizations representing the nation"s experts in infectious diseases medicine, infection prevention in healthcare settings, and public health and disease prevention announced their support for a provision requiring national reporting of healthcare-associated infection (HAI) rates, which is contained within the healthcare reform bill introduced by leaders of the U.S. House of Representatives.
Mental Health

WorldCare Clinical Implements MCC's Imaging Performance Metrics In Support Of Standardized Peformance For Imaging Trials

45th DIA Annual Meeting -- Booth # 1501 -- WorldCare Clinical, LLC (WCC), a leading imaging CRO for clinical trials in the pharmaceutical, biotechnology and medical device industries, announced that it is offering version 1.0 of the Metrics Champion Consortium (MCC) Imaging Performance Metrics to all sponsors" imaging trials beginning July 1, 2009, through its WorldPro™ technology solution. "We are pleased to announce that WCC is implementing the MCC Imaging Performance Metrics," said Dr. Asli Memisoglu, director of biostatistics and data management at WCC. "Through our innovative WorldPro technology platform, WCC is committed to support industry-wide acceptance of MCC"s performance metrics to help ensure best outcomes for our sponsors." The MCC Imaging Performance Metrics Work Group is a non-profit organization made up of biotechnology, pharmaceutical and service provider organizations that work collaboratively to develop and implement standardized performance metrics aimed at improving the efficiency and effectiveness of managing and tracking res needed to successfully run clinical trials. Additionally, WCC will offer statistical analysis of reader reliability, with metrics such as kappa and correlation coefficients, to evaluate reader performance and reliability. "It is critical for a study"s success to have a high level of agreement across readers and good consistency within assessments made by the same reader," said Dr. Richard Walovitch, chief medical officer at WCC. "WCC provides the results from these ongoing evaluations to the client and the reading team in the form of a study newsletter, which helps to facilitate communication of case studies, reader performance, and operational metrics." WCC representatives will be available at Booth # 1501 during this week"s DIA Annual Meeting in San Diego, California, to discuss its application of the MCC and other metrics in imaging trials. For more information or to schedule an appointment, contact Vanessa Conde at (978) 406-5518 or vconde@wcclinical.com. WorldCare Clinical


Add your comment:
Name:
Site address: http://
Your message:
Enter today\\\\'s date, 2 digits
(spam protection):